Cardiovascular-kidney-metabolic syndrome stages demonstrate measurable prevalence across US adults, marking critical shifts in systemic disease progression.
Cross-sectional study evaluates the temporal evolution of cardiovascular-kidney-metabolic syndrome stages from 2011 through 2020 in national survey data.
Characterizing cardiovascular-kidney-metabolic syndrome distribution highlights population health trends, supporting earlier multi-organ interventions.
Abstract
This cross-sectional study assesses the prevalence and temporal evolution of cardiovascular-kidney-metabolic syndrome stages.